For someone living with Crohn’s disease or ulcerative colitis, abdominal pain, nausea, poor appetite, urgent bowel movements, fatigue, and sleep loss can overlap. Cannabis may change how some of those symptoms feel without changing the intestinal inflammation that drives complications.
The legal question has a straightforward answer
Texas DPS lists “Crohn’s disease or other inflammatory bowel disease” as a qualifying category. A permanent Texas resident still needs a registered physician to decide that the potential benefit of low-THC cannabis is reasonable in light of the risk.1
The wording covers IBD, not every gastrointestinal complaint. Irritable bowel syndrome, reflux, and an undiagnosed pattern of abdominal pain are not the same diagnosis. A gastroenterologist should establish what is causing symptoms.
The key distinction is symptoms versus inflammation
The Crohn’s & Colitis Foundation says small studies have found improvements in symptoms such as pain, nausea, and poor appetite, but there is no evidence that medical cannabis reduces IBD inflammation or improves underlying disease activity.2
An updated 2024 meta-analysis found improvements in some quality-of-life and clinical activity measures but no differences in endoscopic disease activity or inflammatory markers.3 That difference matters because uncontrolled inflammation can continue even when symptoms become easier to tolerate.
Keep scheduled lab work, imaging, endoscopy, and gastroenterology follow-up. Do not stop biologics, steroids, immunomodulators, or other IBD treatment without the prescribing clinician.
What to discuss with the GI and cannabis clinicians
- Whether the goal is pain, nausea, appetite, sleep, or another specific symptom.
- Current inflammation markers and the plan for monitoring disease activity.
- Potential interactions with other medicines and additive sedation.
- Whether inhaled products could create avoidable respiratory risk.
- Red flags such as fever, bleeding, severe dehydration, obstruction symptoms, or rapid weight loss.
From evaluation to a Texas prescription
If a registered physician approves low-THC cannabis, that physician enters the prescription in CURT. The patient does not apply for a state card or pay a state registration fee. A licensed dispensary verifies the entry before filling the prescription.4
The official CURT search is available for patients who want to compare participating physicians. Return to the Texas qualifying conditions hub to review the full list.
Clear answers
Frequently Asked Questions
Do Crohn’s disease and ulcerative colitis qualify in Texas?
Yes. Texas includes Crohn’s disease and other inflammatory bowel disease, subject to the program’s residency and physician requirements.
Can cannabis replace IBD medicine?
No. Evidence does not show that cannabis reliably controls intestinal inflammation, so it should not replace disease-modifying treatment or monitoring.
Is IBS included in the IBD category?
IBS and IBD are different diagnoses. The Texas list names Crohn’s disease and other inflammatory bowel disease, not irritable bowel syndrome.